DoD Prostate Cancer Laboratory-Clinical Transition Award
Funding Opportunity Number: W81XWH-14-PCRP-LCTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 29, 2014Award Ceiling: $0Expected Number of Awards: 2Creation Date: May 30, 2014Funding Opportunity Description: The PCRP Laboratory - Clinica...
Source: Grants.gov - May 30, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Request for Letters of Intent: Glucose Responsive Insulin Discovery and Validation
Letter of Interest Deadline: July 11, 2014 JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Letters of Intent (LOI) for the discovery and validation of novel glucose responsive insulin (GRI) drugs for better treatment of insulin-dependent diabetes mellitus (IDDM) and reducing the burden of daily management of the disease, particularly T1D. Proposals (supported by strong rationale and/or preliminary data) will be considered for a maximum budget of up to $500,000* per year for up to 3 years of funding (including 10% indirect ...
Source: ScanGrants feed - May 27, 2014 Category: Research Authors: JDRF Source Type: funding
Call for Nominations: Gary Neil Prize for Innovation in Drug Development
The Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several ...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Nominations: American Society for Clinical Pharmacology and Therapeutics Leon I. Goldberg Young Investigator Award
Call for Nominations: American Society for Clinical Pharmacology and Therapeutics Leon I. Goldberg Young Investigator Award The Leon I. Goldberg Young Investigator Award was established in 1986 to honor a young scientist for accomplishments in the field of clinical pharmacology achieved early in his/her career. The goal of the Leon I. Goldberg Young Investigator Award is to encourage and recognize young scientists active in the field of clinical pharmacology. Eligibility There are no restrictions concerning the scientific field in which nominees have earned their doctoral degrees. Nominees must be no ...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Nominations: Oscar B. Hunter Memorial Award in Therapeutics
The Oscar B. Hunter Memorial Award in Therapeutics was established in 1955 to honor individual scientists for outstanding contributions to clinical pharmacology and therapeutics. This award recognizes a meritorious career in drug research, excellence or contributions in direct patient care, and a distinguished teaching career. The Oscar B. Hunter Memorial Award in Therapeutics is the Society's premier award. The goal of the award is to honor a scientist for outstanding contributions to clinical pharmacology and therapeutics over the individual's professional life. Eligibility A nominee must be able...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Nominations: Rawls-Palmer Progress in Medicine Award
The Rawls-Palmer Progress in Medicine Award was established in 1978 by Dr. W. B. Rawls to further his commitment to continuing medical education and its impact on patient care. This award was founded through the generosity of the late Dr. and Mrs. W.B. Rawls, and honors the memory of their parents. The goal of the Rawls-Palmer Progress in Medicine Award is to incorporate the efforts of modern research in patient care and to help bridge the gap between the results of research and its application in patient care. Eligibility The candidate must be an investigator who is actively involved in high-quality clini...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Nominations: Sheiner-Beal Pharmacometrics Award
The Sheiner-Beal Pharmacometrics Award has been established as an ASCPT Award by the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF) to acknowledge the pioneering contributions of Drs. Lewis B. Sheiner and Stuart Beal to the scientific discipline of pharmacometrics. Definition Pharmacometrics is defined as the science that quantifies drug, disease and clinical trial information to aid efficient drug development, regulatory decisions and rational therapeutic decision making in patients. It uses models that are generally based on pharmacology, physiolog...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Nominations: William B. Abrams Award in Geriatric Clinical Pharmacology
The William B. Abrams Award in Geriatric Clinical Pharmacology was established with support from the Merck Company Foundation in 1996 to honor an investigator in geriatric clinical pharmacology for outstanding contributions to the field. Dr. Abrams, a Past President of ASCPT, had a long and illustrious career in the pharmaceutical industry, mostly at the Merck Research Laboratories. Among his many accomplishments in geriatric clinical pharmacology, he was the founding Co-Editor of the Merck Manual of Geriatrics, created the Scientific Section on Geriatric Clinical Pharmacology of ASCPT, and developed and funded po...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Society for Clinical Pharmacology and Therapeutics Source Type: funding
Call for Early Career Investigator and Underrepresented Minority Travel Fellowship Applications: Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges
Discussion Group Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) in the United States, and is associated with elevated cardiovascular morbidity and mortality. The progression of kidney disease in patients with diabetes occurs over many years, and interventions such as glycemic control and blood pressure lowering with inhibitors of the renin-angiotensin-aldosterone system have been shown to slow this progression. Despite the standard of care, the prevalence of patients with ESRD secondary to diabetic nephropathy continues to rise. Recently, several drugs in late clinical development have fail...
Source: ScanGrants feed - May 19, 2014 Category: Research Authors: New York Academy of Sciences Source Type: funding
DoD Gulf War Illness New Investigator Award
Funding Opportunity Number: W81XWH-14-GWIRP-NIA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 25, 2014Award Ceiling: $0Expected Number of Awards: 2Creation Date: May 07, 2014Funding Opportunity Description: The New Investigator Award (N...
Source: Grants.gov - May 8, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Gulf War Illness Investigator-Initiated Research Award
Funding Opportunity Number: W81XWH-14-GWIRP-IIRA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 25, 2014Award Ceiling: $0Expected Number of Awards: 6Creation Date: May 07, 2014Funding Opportunity Description: The GWIRP Investigator-Initi...
Source: Grants.gov - May 8, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Prostate Cancer Biomarker Development Award
Funding Opportunity Number: W81XWH-14-PCRP-BDA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 24, 2014Award Ceiling: $0Expected Number of Awards: 1Creation Date: May 06, 2014Funding Opportunity Description: Many putative prostate cancer ...
Source: Grants.gov - May 7, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Society for the Advancement of Blood Management-Haemonetics Research Starter Grant
$20,000 one-year Patient Blood Management grant Application deadline July 1, 2014 Funding to begin October 1, 2014 The SABM-Haemonetics Research Starter Grant is intended to advance the field of patient blood management by supporting a young investigator who intends to study methods of promoting blood conservation. This one-year grant provides starter funding to further scientific inquiry and clinical knowledge in the field of patient blood management. Preference will be given to junior faculty who will be advised by an experienced mentor. It is anticipated that the funded study will generate r...
Source: ScanGrants feed - May 6, 2014 Category: Research Authors: Society for the Advancement of Blood Management/Haemonetics Source Type: funding
Drug Therapy Research Award
The Drug Therapy Research Award recognizes outstanding original contributions to the peer-reviewed, primary, biomedical literature that address the therapeutic uses of medications. These can include studies of efficacy, effectiveness, safety, pharmacokinetics, pharmacogenomics, and other pharmacology, toxicology and pharmaceutical sciences research. This award is not intended to recognize practice-based or health services research. (See the Award for Innovation in Pharmacy Practice and the Pharmacy Practice Research Award for these types of research.) Description of Award The recipient of the award receives a ...
Source: ScanGrants feed - April 29, 2014 Category: Research Authors: ASHP Foundation Source Type: funding
Request for Applications: Autism Science Foundation 2014 Undergraduate Summer Research
Applications Due: April 18, 2014 Notification of Awards: May, 2014 The Autism Science Foundation invites applications from highly qualified undergraduates interested in pursuing basic and clinical research relevant to autism spectrum disorders during the summer. The proposed research must be scientifically linked to autism or a closely related field. Autism Science Foundation will consider all areas of related basic and clinical research including but not limited to: human behavior across the lifespan (language, learning, communication, social function, epilepsy, sleep, self-injurious behavior, catat...
Source: ScanGrants feed - April 1, 2014 Category: Research Authors: Autism Science Foundation Source Type: funding
